Allocations
Arrowpoint Advisory has advised BasePower on its GBP50 million five-year framework project funding agreement with SDCL Energy Efficiency Income Trust plc (SEEIT).
BasePower develops and operates on-site power generation projects for commercial and industrial clients in the UK utilising a range of energy efficiency and carbon reducing technologies including Combined Heat and Power (CHP), solar photovoltaic (PV) and microgrid projects.
The agreement will allow BasePower to accelerate the delivery of sustainable energy projects, having already developed award-winning energy centres for some of the UK’s largest food and automotive manufacturers seeking to reduce their energy costs and carbon footprint.
3i Infrastructure has agreed to invest cEUR182 million to acquire a 60 per cent stake in DNS:NET and to provide additional funding for the future growth of the business.
DNS:NET is an independent telecommunications provider in Germany. 3i Infrastructure is buying its stake from Deutsche Beteiligungs AG’s (DBAG), DBAG ECF, a private equity fund managed by DBAG, and Founder and CEO Alexander Lucke, with the latter reinvesting alongside 3i Infrastructure to retain a 40 per cent stake. Completion is expected to take place in June 2021.
Established in 1998, DNS:NET owns the largest independent fibre-to-the-cabinet network in the Berlin area,
PSG, a specialist growth equity firm partnering with middle-market software and technology-enabled service companies to help them navigate transformational growth, has signed a definitive agreement to sell Pineapple Payments, a payments technology provider, to Fiserv, Inc (NASDAQ: FISV), a global specialist in payments and financial services technology solutions.
Pineapple will join the Global Business Solutions division of Fiserv as part of the Partner Solutions business unit. Founded in 2016, Pineapple Payments provides payment processing, proprietary technology, and omni-channel payment acceptance solutions for integrated software vendors (ISVs) and small and medium businesses (SMBs). After partnering with PSG in 2017, Pineapple
PineBridge Investments (PineBridge), a private, global asset manager focused on active, high-conviction investing, has appointed Kate Faraday as Global Head of Corporate Responsibility.
In this newly created role, Faraday will report directly to PineBridge’s CEO, Greg Ehret. Her primary responsibilities will be to work closely with PineBridge’s Corporate Responsibility Steering Committee, which oversees the firm’s subcommittees. Those subcommittees are dedicated to ESG Investment, Diversity & Inclusion, Stewardship and Company Responsibility. Ms. Faraday will play an active role in each of these functions, ensuring alignment, collaboration and sharing of best practices across PineBridge.
In this new role, Faraday will oversee
Kirkland & Ellis is advising TDR Capital LLP, a private equity firm, on the recommended offer for the entire issued, and to be issued, ordinary share capital of Arrow.
As part of the offer, shareholders of Arrow have the opportunity to elect to receive a share alternative in lieu of the cash offer. The acquisition will be implemented by way of a scheme of arrangement and values Arrow at approximately GBP563 million.
Arrow was founded in the United Kingdom in 2005, with the aim of identifying, acquiring and managing secured and unsecured loan and real estate portfolios from
Alex Di Santo, group head of private equity at Crestbridge outlines four considerations for venture capital managers looking to launch their first fund.
Funds managed by SK Capital Partners LP, a private investment firm focused on the specialty materials, chemicals and pharmaceuticals sectors, have completed the previously announced acquisition of the Blow-Fill-Seal (BFS) Sterile Contract Development and Manufacturing business from Catalent Pharma Solutions.
The business has been renamed Woodstock Sterile Solutions (Woodstock), reflecting its long-standing, rich heritage in the Woodstock, Illinois community.
Woodstock is a leading BFS sterile contract development and manufacturing organisation (CDMO) that operates out of a single site in Woodstock, Illinois, focusing on complex clinical to commercial stage formulation and manufacturing. The Company supports a global, blue-chip customer base with
Collectia today announces that it has completed the acquisition of the Danish operations of Kredinor . Financial terms of the deal have not been disclosed.
Kredinor A/S is the oldest provider of debt collection services in Denmark with over 150 years of experience, and is particularly strong within the utility and SME sectors with its sector leading subscription service.
Kredinor A/S is headquartered in Ballerup, Denmark and works on behalf of over 3,000 corporate clients and employs c44 FTEs.
Silverfleet Capital invested in Collectia, a tech-enabled credit management services provider, in early 2020 to support its continued international
Global investment bank GCA Altium has advised the shareholders of Retrogenix, an early-stage contract research organisation (CRO) providing specialised bioanalytical services, on its sale to US-headquartered Charles River Laboratories.
Founded in 2008, Derbyshire-based Retrogenix offers cell microarray services for target receptor identification, off-target profiling, and target deconvolution on a wide range of novel therapeutics including biologics, cell therapies and small molecules. It provides the only commercially available platform for off-target screening for pre-clinical safety assurance in CAR T and other cell therapies.
Leveraging one of the world’s largest protein libraries which it has developed over the last ten years,
Align Capital Partners (ACP) has completed the majority recapitalisation of Custom Veterinary Services (CVS), a custom formulator and contract manufacturer exclusively focused on the animal health industry.
The Company’s FDA-registered facility in Miami, Florida produces nutritional supplements, dermatological, and grooming products for companion animals.
Founded by Ruben Martinez in 2005, CVS serves customers ranging from well-established animal health organisations to prospering e-commerce-focused brands. Under Ruben’s leadership, the Company has partnered with over 100 clients to date; working with them to identify their product needs, develop formulations, establish packaging, and scale up to production.
“CVS’ commitment is to produce
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm